The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Liver Diseases Treatment Market Research Report 2025

Global Liver Diseases Treatment Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1721732

No of Pages : 222

Ask Your Query

Synopsis

Liver disease, greenish-yellow or greenish-brown skin, often due to intrahepatic cholestasis, intrahepatic or extrahepatic biliary obstruction.The sex hormone secreted in liver disease cannot degrade and inactivate in time, which leads to hyperemia and dilatation of superficial arterioles.

The global Liver Diseases Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Liver Diseases Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Liver Diseases Treatment.

Report Scope

The Liver Diseases Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Liver Diseases Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Liver Diseases Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Abbott Laboratories
  • Bayer Schering
  • Eli Lilly
  • Merck
  • Novartis
  • Pfizer
  • Roche
  • Sanofi-Aventis
  • Takeda Pharmaceutical
  • Zydus Pharmaceuticals
  • Glaxosmithkline
  • Bristol-Myers Squibb
  • General Electric
  • Koninklijke Philips
  • Siemens
  • Canon Medical Systems Corp
  • Hitachi
  • Elekta
  • Neusoft Corporation
  • Samsung Healthcare
  • BPL Medical Technologies
  • Cura Healthcare
  • Angion Biomedica
  • Achillion Pharmaceuticals
  • Gilead Sciences
  • LG Life Sciences
  • Verva Pharmaceuticals
  • Shenzhen Kangtai Biological Products
  • Raptor Pharmaceuticals
  • ProMetic Life Sciences
  • Phenex Pharmaceuticals

Segment by Type

  • Chemotherapy Drugs
  • Targeted Therapy
  • Anti-Viral Drugs
  • Immunoglobulins
  • Corticosteroids
  • Vaccines
  • Anti-Rejection Drugs/Immunosuppressant

Segment by Application

  • Cancer
  • Hepatitis
  • Cirrhosis
  • Other

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Liver Diseases Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Liver Diseases Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemotherapy Drugs
1.2.3 Targeted Therapy
1.2.4 Anti-Viral Drugs
1.2.5 Immunoglobulins
1.2.6 Corticosteroids
1.2.7 Vaccines
1.2.8 Anti-Rejection Drugs/Immunosuppressant
1.3 Market by Application
1.3.1 Global Liver Diseases Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Hepatitis
1.3.4 Cirrhosis
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Liver Diseases Treatment Market Perspective (2019-2030)
2.2 Liver Diseases Treatment Growth Trends by Region
2.2.1 Global Liver Diseases Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Liver Diseases Treatment Historic Market Size by Region (2019-2024)
2.2.3 Liver Diseases Treatment Forecasted Market Size by Region (2025-2030)
2.3 Liver Diseases Treatment Market Dynamics
2.3.1 Liver Diseases Treatment Industry Trends
2.3.2 Liver Diseases Treatment Market Drivers
2.3.3 Liver Diseases Treatment Market Challenges
2.3.4 Liver Diseases Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Liver Diseases Treatment Players by Revenue
3.1.1 Global Top Liver Diseases Treatment Players by Revenue (2019-2024)
3.1.2 Global Liver Diseases Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Liver Diseases Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Liver Diseases Treatment Revenue
3.4 Global Liver Diseases Treatment Market Concentration Ratio
3.4.1 Global Liver Diseases Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Liver Diseases Treatment Revenue in 2023
3.5 Liver Diseases Treatment Key Players Head office and Area Served
3.6 Key Players Liver Diseases Treatment Product Solution and Service
3.7 Date of Enter into Liver Diseases Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Liver Diseases Treatment Breakdown Data by Type
4.1 Global Liver Diseases Treatment Historic Market Size by Type (2019-2024)
4.2 Global Liver Diseases Treatment Forecasted Market Size by Type (2025-2030)
5 Liver Diseases Treatment Breakdown Data by Application
5.1 Global Liver Diseases Treatment Historic Market Size by Application (2019-2024)
5.2 Global Liver Diseases Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Liver Diseases Treatment Market Size (2019-2030)
6.2 North America Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Liver Diseases Treatment Market Size by Country (2019-2024)
6.4 North America Liver Diseases Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Liver Diseases Treatment Market Size (2019-2030)
7.2 Europe Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Liver Diseases Treatment Market Size by Country (2019-2024)
7.4 Europe Liver Diseases Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Liver Diseases Treatment Market Size (2019-2030)
8.2 Asia-Pacific Liver Diseases Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Liver Diseases Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Liver Diseases Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Liver Diseases Treatment Market Size (2019-2030)
9.2 Latin America Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Liver Diseases Treatment Market Size by Country (2019-2024)
9.4 Latin America Liver Diseases Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Liver Diseases Treatment Market Size (2019-2030)
10.2 Middle East & Africa Liver Diseases Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Liver Diseases Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Liver Diseases Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Liver Diseases Treatment Introduction
11.1.4 Abbott Laboratories Revenue in Liver Diseases Treatment Business (2019-2024)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer Schering
11.2.1 Bayer Schering Company Detail
11.2.2 Bayer Schering Business Overview
11.2.3 Bayer Schering Liver Diseases Treatment Introduction
11.2.4 Bayer Schering Revenue in Liver Diseases Treatment Business (2019-2024)
11.2.5 Bayer Schering Recent Development
11.3 Eli Lilly
11.3.1 Eli Lilly Company Detail
11.3.2 Eli Lilly Business Overview
11.3.3 Eli Lilly Liver Diseases Treatment Introduction
11.3.4 Eli Lilly Revenue in Liver Diseases Treatment Business (2019-2024)
11.3.5 Eli Lilly Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Liver Diseases Treatment Introduction
11.4.4 Merck Revenue in Liver Diseases Treatment Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Detail
11.5.2 Novartis Business Overview
11.5.3 Novartis Liver Diseases Treatment Introduction
11.5.4 Novartis Revenue in Liver Diseases Treatment Business (2019-2024)
11.5.5 Novartis Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Liver Diseases Treatment Introduction
11.6.4 Pfizer Revenue in Liver Diseases Treatment Business (2019-2024)
11.6.5 Pfizer Recent Development
11.7 Roche
11.7.1 Roche Company Detail
11.7.2 Roche Business Overview
11.7.3 Roche Liver Diseases Treatment Introduction
11.7.4 Roche Revenue in Liver Diseases Treatment Business (2019-2024)
11.7.5 Roche Recent Development
11.8 Sanofi-Aventis
11.8.1 Sanofi-Aventis Company Detail
11.8.2 Sanofi-Aventis Business Overview
11.8.3 Sanofi-Aventis Liver Diseases Treatment Introduction
11.8.4 Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2019-2024)
11.8.5 Sanofi-Aventis Recent Development
11.9 Takeda Pharmaceutical
11.9.1 Takeda Pharmaceutical Company Detail
11.9.2 Takeda Pharmaceutical Business Overview
11.9.3 Takeda Pharmaceutical Liver Diseases Treatment Introduction
11.9.4 Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2019-2024)
11.9.5 Takeda Pharmaceutical Recent Development
11.10 Zydus Pharmaceuticals
11.10.1 Zydus Pharmaceuticals Company Detail
11.10.2 Zydus Pharmaceuticals Business Overview
11.10.3 Zydus Pharmaceuticals Liver Diseases Treatment Introduction
11.10.4 Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024)
11.10.5 Zydus Pharmaceuticals Recent Development
11.11 Glaxosmithkline
11.11.1 Glaxosmithkline Company Detail
11.11.2 Glaxosmithkline Business Overview
11.11.3 Glaxosmithkline Liver Diseases Treatment Introduction
11.11.4 Glaxosmithkline Revenue in Liver Diseases Treatment Business (2019-2024)
11.11.5 Glaxosmithkline Recent Development
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Detail
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Liver Diseases Treatment Introduction
11.12.4 Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2019-2024)
11.12.5 Bristol-Myers Squibb Recent Development
11.13 General Electric
11.13.1 General Electric Company Detail
11.13.2 General Electric Business Overview
11.13.3 General Electric Liver Diseases Treatment Introduction
11.13.4 General Electric Revenue in Liver Diseases Treatment Business (2019-2024)
11.13.5 General Electric Recent Development
11.14 Koninklijke Philips
11.14.1 Koninklijke Philips Company Detail
11.14.2 Koninklijke Philips Business Overview
11.14.3 Koninklijke Philips Liver Diseases Treatment Introduction
11.14.4 Koninklijke Philips Revenue in Liver Diseases Treatment Business (2019-2024)
11.14.5 Koninklijke Philips Recent Development
11.15 Siemens
11.15.1 Siemens Company Detail
11.15.2 Siemens Business Overview
11.15.3 Siemens Liver Diseases Treatment Introduction
11.15.4 Siemens Revenue in Liver Diseases Treatment Business (2019-2024)
11.15.5 Siemens Recent Development
11.16 Canon Medical Systems Corp
11.16.1 Canon Medical Systems Corp Company Detail
11.16.2 Canon Medical Systems Corp Business Overview
11.16.3 Canon Medical Systems Corp Liver Diseases Treatment Introduction
11.16.4 Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2019-2024)
11.16.5 Canon Medical Systems Corp Recent Development
11.17 Hitachi
11.17.1 Hitachi Company Detail
11.17.2 Hitachi Business Overview
11.17.3 Hitachi Liver Diseases Treatment Introduction
11.17.4 Hitachi Revenue in Liver Diseases Treatment Business (2019-2024)
11.17.5 Hitachi Recent Development
11.18 Elekta
11.18.1 Elekta Company Detail
11.18.2 Elekta Business Overview
11.18.3 Elekta Liver Diseases Treatment Introduction
11.18.4 Elekta Revenue in Liver Diseases Treatment Business (2019-2024)
11.18.5 Elekta Recent Development
11.19 Neusoft Corporation
11.19.1 Neusoft Corporation Company Detail
11.19.2 Neusoft Corporation Business Overview
11.19.3 Neusoft Corporation Liver Diseases Treatment Introduction
11.19.4 Neusoft Corporation Revenue in Liver Diseases Treatment Business (2019-2024)
11.19.5 Neusoft Corporation Recent Development
11.20 Samsung Healthcare
11.20.1 Samsung Healthcare Company Detail
11.20.2 Samsung Healthcare Business Overview
11.20.3 Samsung Healthcare Liver Diseases Treatment Introduction
11.20.4 Samsung Healthcare Revenue in Liver Diseases Treatment Business (2019-2024)
11.20.5 Samsung Healthcare Recent Development
11.21 BPL Medical Technologies
11.21.1 BPL Medical Technologies Company Detail
11.21.2 BPL Medical Technologies Business Overview
11.21.3 BPL Medical Technologies Liver Diseases Treatment Introduction
11.21.4 BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2019-2024)
11.21.5 BPL Medical Technologies Recent Development
11.22 Cura Healthcare
11.22.1 Cura Healthcare Company Detail
11.22.2 Cura Healthcare Business Overview
11.22.3 Cura Healthcare Liver Diseases Treatment Introduction
11.22.4 Cura Healthcare Revenue in Liver Diseases Treatment Business (2019-2024)
11.22.5 Cura Healthcare Recent Development
11.23 Angion Biomedica
11.23.1 Angion Biomedica Company Detail
11.23.2 Angion Biomedica Business Overview
11.23.3 Angion Biomedica Liver Diseases Treatment Introduction
11.23.4 Angion Biomedica Revenue in Liver Diseases Treatment Business (2019-2024)
11.23.5 Angion Biomedica Recent Development
11.24 Achillion Pharmaceuticals
11.24.1 Achillion Pharmaceuticals Company Detail
11.24.2 Achillion Pharmaceuticals Business Overview
11.24.3 Achillion Pharmaceuticals Liver Diseases Treatment Introduction
11.24.4 Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024)
11.24.5 Achillion Pharmaceuticals Recent Development
11.25 Gilead Sciences
11.25.1 Gilead Sciences Company Detail
11.25.2 Gilead Sciences Business Overview
11.25.3 Gilead Sciences Liver Diseases Treatment Introduction
11.25.4 Gilead Sciences Revenue in Liver Diseases Treatment Business (2019-2024)
11.25.5 Gilead Sciences Recent Development
11.26 LG Life Sciences
11.26.1 LG Life Sciences Company Detail
11.26.2 LG Life Sciences Business Overview
11.26.3 LG Life Sciences Liver Diseases Treatment Introduction
11.26.4 LG Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024)
11.26.5 LG Life Sciences Recent Development
11.27 Verva Pharmaceuticals
11.27.1 Verva Pharmaceuticals Company Detail
11.27.2 Verva Pharmaceuticals Business Overview
11.27.3 Verva Pharmaceuticals Liver Diseases Treatment Introduction
11.27.4 Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024)
11.27.5 Verva Pharmaceuticals Recent Development
11.28 Shenzhen Kangtai Biological Products
11.28.1 Shenzhen Kangtai Biological Products Company Detail
11.28.2 Shenzhen Kangtai Biological Products Business Overview
11.28.3 Shenzhen Kangtai Biological Products Liver Diseases Treatment Introduction
11.28.4 Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2019-2024)
11.28.5 Shenzhen Kangtai Biological Products Recent Development
11.29 Raptor Pharmaceuticals
11.29.1 Raptor Pharmaceuticals Company Detail
11.29.2 Raptor Pharmaceuticals Business Overview
11.29.3 Raptor Pharmaceuticals Liver Diseases Treatment Introduction
11.29.4 Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024)
11.29.5 Raptor Pharmaceuticals Recent Development
11.30 ProMetic Life Sciences
11.30.1 ProMetic Life Sciences Company Detail
11.30.2 ProMetic Life Sciences Business Overview
11.30.3 ProMetic Life Sciences Liver Diseases Treatment Introduction
11.30.4 ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024)
11.30.5 ProMetic Life Sciences Recent Development
11.31 Phenex Pharmaceuticals
11.31.1 Phenex Pharmaceuticals Company Detail
11.31.2 Phenex Pharmaceuticals Business Overview
11.31.3 Phenex Pharmaceuticals Liver Diseases Treatment Introduction
11.31.4 Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024)
11.31.5 Phenex Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Liver Diseases Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy Drugs
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Anti-Viral Drugs
Table 5. Key Players of Immunoglobulins
Table 6. Key Players of Corticosteroids
Table 7. Key Players of Vaccines
Table 8. Key Players of Anti-Rejection Drugs/Immunosuppressant
Table 9. Global Liver Diseases Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 10. Global Liver Diseases Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 11. Global Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 12. Global Liver Diseases Treatment Market Share by Region (2019-2024)
Table 13. Global Liver Diseases Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 14. Global Liver Diseases Treatment Market Share by Region (2025-2030)
Table 15. Liver Diseases Treatment Market Trends
Table 16. Liver Diseases Treatment Market Drivers
Table 17. Liver Diseases Treatment Market Challenges
Table 18. Liver Diseases Treatment Market Restraints
Table 19. Global Liver Diseases Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 20. Global Liver Diseases Treatment Market Share by Players (2019-2024)
Table 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
Table 22. Ranking of Global Top Liver Diseases Treatment Companies by Revenue (US$ Million) in 2023
Table 23. Global 5 Largest Players Market Share by Liver Diseases Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Liver Diseases Treatment Product Solution and Service
Table 26. Date of Enter into Liver Diseases Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Liver Diseases Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 29. Global Liver Diseases Treatment Revenue Market Share by Type (2019-2024)
Table 30. Global Liver Diseases Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 31. Global Liver Diseases Treatment Revenue Market Share by Type (2025-2030)
Table 32. Global Liver Diseases Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 33. Global Liver Diseases Treatment Revenue Market Share by Application (2019-2024)
Table 34. Global Liver Diseases Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 35. Global Liver Diseases Treatment Revenue Market Share by Application (2025-2030)
Table 36. North America Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. North America Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 38. North America Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 39. Europe Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 40. Europe Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 41. Europe Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 42. Asia-Pacific Liver Diseases Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 43. Asia-Pacific Liver Diseases Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 44. Asia-Pacific Liver Diseases Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 45. Latin America Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Latin America Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 47. Latin America Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 48. Middle East & Africa Liver Diseases Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 49. Middle East & Africa Liver Diseases Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 50. Middle East & Africa Liver Diseases Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 51. Abbott Laboratories Company Detail
Table 52. Abbott Laboratories Business Overview
Table 53. Abbott Laboratories Liver Diseases Treatment Product
Table 54. Abbott Laboratories Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 55. Abbott Laboratories Recent Development
Table 56. Bayer Schering Company Detail
Table 57. Bayer Schering Business Overview
Table 58. Bayer Schering Liver Diseases Treatment Product
Table 59. Bayer Schering Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 60. Bayer Schering Recent Development
Table 61. Eli Lilly Company Detail
Table 62. Eli Lilly Business Overview
Table 63. Eli Lilly Liver Diseases Treatment Product
Table 64. Eli Lilly Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 65. Eli Lilly Recent Development
Table 66. Merck Company Detail
Table 67. Merck Business Overview
Table 68. Merck Liver Diseases Treatment Product
Table 69. Merck Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 70. Merck Recent Development
Table 71. Novartis Company Detail
Table 72. Novartis Business Overview
Table 73. Novartis Liver Diseases Treatment Product
Table 74. Novartis Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Pfizer Company Detail
Table 77. Pfizer Business Overview
Table 78. Pfizer Liver Diseases Treatment Product
Table 79. Pfizer Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. Roche Company Detail
Table 82. Roche Business Overview
Table 83. Roche Liver Diseases Treatment Product
Table 84. Roche Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 85. Roche Recent Development
Table 86. Sanofi-Aventis Company Detail
Table 87. Sanofi-Aventis Business Overview
Table 88. Sanofi-Aventis Liver Diseases Treatment Product
Table 89. Sanofi-Aventis Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 90. Sanofi-Aventis Recent Development
Table 91. Takeda Pharmaceutical Company Detail
Table 92. Takeda Pharmaceutical Business Overview
Table 93. Takeda Pharmaceutical Liver Diseases Treatment Product
Table 94. Takeda Pharmaceutical Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 95. Takeda Pharmaceutical Recent Development
Table 96. Zydus Pharmaceuticals Company Detail
Table 97. Zydus Pharmaceuticals Business Overview
Table 98. Zydus Pharmaceuticals Liver Diseases Treatment Product
Table 99. Zydus Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 100. Zydus Pharmaceuticals Recent Development
Table 101. Glaxosmithkline Company Detail
Table 102. Glaxosmithkline Business Overview
Table 103. Glaxosmithkline Liver Diseases Treatment Product
Table 104. Glaxosmithkline Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 105. Glaxosmithkline Recent Development
Table 106. Bristol-Myers Squibb Company Detail
Table 107. Bristol-Myers Squibb Business Overview
Table 108. Bristol-Myers Squibb Liver Diseases Treatment Product
Table 109. Bristol-Myers Squibb Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 110. Bristol-Myers Squibb Recent Development
Table 111. General Electric Company Detail
Table 112. General Electric Business Overview
Table 113. General Electric Liver Diseases Treatment Product
Table 114. General Electric Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 115. General Electric Recent Development
Table 116. Koninklijke Philips Company Detail
Table 117. Koninklijke Philips Business Overview
Table 118. Koninklijke Philips Liver Diseases Treatment Product
Table 119. Koninklijke Philips Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 120. Koninklijke Philips Recent Development
Table 121. Siemens Company Detail
Table 122. Siemens Business Overview
Table 123. Siemens Liver Diseases Treatment Product
Table 124. Siemens Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 125. Siemens Recent Development
Table 126. Canon Medical Systems Corp Company Detail
Table 127. Canon Medical Systems Corp Business Overview
Table 128. Canon Medical Systems Corp Liver Diseases Treatment Product
Table 129. Canon Medical Systems Corp Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 130. Canon Medical Systems Corp Recent Development
Table 131. Hitachi Company Detail
Table 132. Hitachi Business Overview
Table 133. Hitachi Liver Diseases Treatment Product
Table 134. Hitachi Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 135. Hitachi Recent Development
Table 136. Elekta Company Detail
Table 137. Elekta Business Overview
Table 138. Elekta Liver Diseases Treatment Product
Table 139. Elekta Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 140. Elekta Recent Development
Table 141. Neusoft Corporation Company Detail
Table 142. Neusoft Corporation Business Overview
Table 143. Neusoft Corporation Liver Diseases Treatment Product
Table 144. Neusoft Corporation Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 145. Neusoft Corporation Recent Development
Table 146. Samsung Healthcare Company Detail
Table 147. Samsung Healthcare Business Overview
Table 148. Samsung Healthcare Liver Diseases Treatment Product
Table 149. Samsung Healthcare Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 150. Samsung Healthcare Recent Development
Table 151. BPL Medical Technologies Company Detail
Table 152. BPL Medical Technologies Business Overview
Table 153. BPL Medical Technologies Liver Diseases Treatment Product
Table 154. BPL Medical Technologies Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 155. BPL Medical Technologies Recent Development
Table 156. Cura Healthcare Company Detail
Table 157. Cura Healthcare Business Overview
Table 158. Cura Healthcare Liver Diseases Treatment Product
Table 159. Cura Healthcare Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 160. Cura Healthcare Recent Development
Table 161. Angion Biomedica Company Detail
Table 162. Angion Biomedica Business Overview
Table 163. Angion Biomedica Liver Diseases Treatment Product
Table 164. Angion Biomedica Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 165. Angion Biomedica Recent Development
Table 166. Achillion Pharmaceuticals Company Detail
Table 167. Achillion Pharmaceuticals Business Overview
Table 168. Achillion Pharmaceuticals Liver Diseases Treatment Product
Table 169. Achillion Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 170. Achillion Pharmaceuticals Recent Development
Table 171. Gilead Sciences Company Detail
Table 172. Gilead Sciences Business Overview
Table 173. Gilead Sciences Liver Diseases Treatment Product
Table 174. Gilead Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 175. Gilead Sciences Recent Development
Table 176. LG Life Sciences Company Detail
Table 177. LG Life Sciences Business Overview
Table 178. LG Life Sciences Liver Diseases Treatment Product
Table 179. LG Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 180. LG Life Sciences Recent Development
Table 181. Verva Pharmaceuticals Company Detail
Table 182. Verva Pharmaceuticals Business Overview
Table 183. Verva Pharmaceuticals Liver Diseases Treatment Product
Table 184. Verva Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 185. Verva Pharmaceuticals Recent Development
Table 186. Shenzhen Kangtai Biological Products Company Detail
Table 187. Shenzhen Kangtai Biological Products Business Overview
Table 188. Shenzhen Kangtai Biological Products Liver Diseases Treatment Product
Table 189. Shenzhen Kangtai Biological Products Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 190. Shenzhen Kangtai Biological Products Recent Development
Table 191. Raptor Pharmaceuticals Company Detail
Table 192. Raptor Pharmaceuticals Business Overview
Table 193. Raptor Pharmaceuticals Liver Diseases Treatment Product
Table 194. Raptor Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 195. Raptor Pharmaceuticals Recent Development
Table 196. ProMetic Life Sciences Company Detail
Table 197. ProMetic Life Sciences Business Overview
Table 198. ProMetic Life Sciences Liver Diseases Treatment Product
Table 199. ProMetic Life Sciences Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 200. ProMetic Life Sciences Recent Development
Table 201. Phenex Pharmaceuticals Company Detail
Table 202. Phenex Pharmaceuticals Business Overview
Table 203. Phenex Pharmaceuticals Liver Diseases Treatment Product
Table 204. Phenex Pharmaceuticals Revenue in Liver Diseases Treatment Business (2019-2024) & (US$ Million)
Table 205. Phenex Pharmaceuticals Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Liver Diseases Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Liver Diseases Treatment Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Drugs Features
Figure 4. Targeted Therapy Features
Figure 5. Anti-Viral Drugs Features
Figure 6. Immunoglobulins Features
Figure 7. Corticosteroids Features
Figure 8. Vaccines Features
Figure 9. Anti-Rejection Drugs/Immunosuppressant Features
Figure 10. Global Liver Diseases Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Liver Diseases Treatment Market Share by Application: 2023 VS 2030
Figure 12. Cancer Case Studies
Figure 13. Hepatitis Case Studies
Figure 14. Cirrhosis Case Studies
Figure 15. Other Case Studies
Figure 16. Liver Diseases Treatment Report Years Considered
Figure 17. Global Liver Diseases Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 18. Global Liver Diseases Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 19. Global Liver Diseases Treatment Market Share by Region: 2023 VS 2030
Figure 20. Global Liver Diseases Treatment Market Share by Players in 2023
Figure 21. Global Top Liver Diseases Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Liver Diseases Treatment as of 2023)
Figure 22. The Top 10 and 5 Players Market Share by Liver Diseases Treatment Revenue in 2023
Figure 23. North America Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. North America Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 25. United States Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Canada Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Europe Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 29. Germany Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. France Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. U.K. Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Italy Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Russia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Nordic Countries Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Asia-Pacific Liver Diseases Treatment Market Share by Region (2019-2030)
Figure 37. China Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Japan Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. South Korea Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Southeast Asia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. India Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Australia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Latin America Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 45. Mexico Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Brazil Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Liver Diseases Treatment Market Share by Country (2019-2030)
Figure 49. Turkey Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Liver Diseases Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Abbott Laboratories Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 52. Bayer Schering Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 53. Eli Lilly Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 54. Merck Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 55. Novartis Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 56. Pfizer Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 57. Roche Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 58. Sanofi-Aventis Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 59. Takeda Pharmaceutical Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 60. Zydus Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 61. Glaxosmithkline Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 63. General Electric Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 64. Koninklijke Philips Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 65. Siemens Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 66. Canon Medical Systems Corp Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 67. Hitachi Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 68. Elekta Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 69. Neusoft Corporation Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 70. Samsung Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 71. BPL Medical Technologies Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 72. Cura Healthcare Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 73. Angion Biomedica Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 74. Achillion Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 75. Gilead Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 76. LG Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 77. Verva Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 78. Shenzhen Kangtai Biological Products Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 79. Raptor Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 80. ProMetic Life Sciences Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 81. Phenex Pharmaceuticals Revenue Growth Rate in Liver Diseases Treatment Business (2019-2024)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock